JP Morgan Chase
GMED icon

JP Morgan Chase’s Globus Medical GMED Stock Holding History

JP Morgan Chase’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-75,000
Closed -$3.79M – 5722
2018
Q2 		$3.79M Buy
+75,000
New +$3.91M ﹤0.01% 2908

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

JP Morgan Chase's GMED Position: Q2 2026 in Review

JP Morgan Chase increased its Globus Medical (GMED) stake by 5.7% in Q2 2026, buying an estimated $12.6M and bringing the position to 2,743,850 shares worth $231M. The position accounts for 0.01% of the portfolio, ranked #705.

JP Morgan Chase first reported a position in GMED in Q3 2013 and has held it in 48 quarters since. The position peaked at $271M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • JP Morgan Chase held 2,743,850 shares of Globus Medical worth $231M as of Q2 2026.
  • JP Morgan Chase bought 148,542 Globus Medical shares in Q2 2026, an estimated $12.6M.
  • Globus Medical made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #705 holding.
  • JP Morgan Chase first reported a position in Globus Medical in Q3 2013 and has held it in 48 quarters since.
  • JP Morgan Chase's Globus Medical position peaked at $271M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.